What Analysts Think of Palantir Stock Ahead of Earnings

Palantir Technologies (PLTR) is set to report second-quarter results today, with analysts anticipating revenue of $939.6 million and adjusted EPS of $0.14. Despite PLTR's stock more than doubling this year to become the S&P 500's top performer, Wall Street analysts remain largely cautious, with only two of 12 issuing 'buy' ratings and a consensus price target of approximately $107, significantly below its current trading price near $160. This divergence underscores a key debate among investors regarding the company's AI platform's commercial growth potential, particularly beyond its established government business.

Analysis

Palantir Technologies (PLTR) is set to report second-quarter earnings, creating a pivotal moment for the stock, which has more than doubled year-to-date to become the S&P 500's top performer. This rally has created a significant disconnect with Wall Street sentiment, as only two of twelve analysts tracked by Visible Alpha rate the stock as a 'buy'. The consensus price target of approximately $107 stands roughly 30% below its recent trading price near $160, signaling widespread skepticism about its current valuation. The core of the debate centers on the growth trajectory of Palantir's Artificial Intelligence Platform (AIP) in the commercial sector. Bulls, such as Wedbush, argue the Street is underestimating a potential $1 billion-plus revenue stream from this business. Meanwhile, consensus estimates are already high, projecting Q2 revenue of $939.6 million, a 39% year-over-year increase, and adjusted EPS of 14 cents. The upcoming report will be a critical test of whether the company's performance and forward guidance can substantiate its premium valuation and resolve the stark divergence between market momentum and analyst caution.

Key Decisions for Investors

• Investors should scrutinize the upcoming earnings report for commercial revenue growth and forward guidance on the AI platform, as these will be key to validating the bull thesis against widespread analyst skepticism.
• Given the 30% downside implied by the consensus price target ($107) versus the current price (~$160), investors must weigh the substantial valuation risk against the high growth expectations (39% YoY revenue) already priced into the stock.
• The extreme divergence between the stock's performance and analyst ratings suggests high volatility around the earnings release; it may be prudent to review position sizing or consider hedging strategies ahead of the announcement.